Cancer Radiation Therapy Clinical Trials

• Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
  ClinicalTrials.gov Identifier: NCT00081029 - Recruiting
  Hypopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; radiation toxicity
  
• Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00438659 - Active, not recruiting
  Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• Radiation Therapy With or Without Epoetin alfa in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017277 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00068237 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; metastatic squamous neck cancer with occult primary; ...
  
• Radiation Therapy With or Without Epoetin alfa in Anemic Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004917 - Active, not recruiting
  Anemia; Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00415025 - Active, not recruiting
  Head and Neck Cancer; Long-Term Effects Secondary to Cancer Therapy in Adults; Oral Complications of Cancer and Cancer Therapy; Oral Complications of Chemotherapy and Head/Neck Radiation; Radiation Toxicity
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
  ClinicalTrials.gov Identifier: NCT00017004 - Active, not recruiting
  Anemia; Cervical Cancer; Drug Toxicity; Quality of Life; radiation toxicity
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00025298 - Active, not recruiting
  stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer; oral complications of cancer and cancer therapy; ...
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00033657 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00033449 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00452946 - Recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Complications; Liver Cancer; Pancreatic Cancer; Radiation Toxicity
  
• Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
  
• Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00083057 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• External-Beam Radiation Therapy or Implant Radiation Therapy Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage I Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00376844 - Active, not recruiting
  Endometrial Cancer
  
• Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients with Stage I or Stage II Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00006027 - Active, not recruiting
  Endometrial Cancer
  
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003777 - Active, not recruiting
  Oral Cancer; Throat Cancer; Nose Cancer
  
• A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer
  ClinicalTrials.gov Identifier: NCT00436397 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00049283 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00274937 - Recruiting
  Nasopharyngeal Cancer; Oral Complications of Chemotherapy and Head and Neck Radiation
  
• RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
  ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
  lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
  
• Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00017095 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
  
• Peripheral Stem Cell Transplantation, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00005941 - Active, not recruiting
  Cervical Cancer; Vaginal Cancer
  
• Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
  ClinicalTrials.gov Identifier: NCT00004256 - Active, not recruiting
  Laryngeal Cancer
  
• Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
  
• Gene Therapy and Surgery Followed by Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00017173 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
  
• Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00093652 - Active, not recruiting
  Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
  
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
  Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
  
• Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003422 - Active, not recruiting
  stage I rectal cancer; stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00104910 - Recruiting
  Cervical Cancer
  
• Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Treating Women With Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005983 - Active, not recruiting
  stage II breast cancer
  
• Palifermin in Reducing or Preventing Mucositis in Patients Who Are Receiving Radiation Therapy and Chemotherapy Followed by an Autologous Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00126529 - Recruiting
  Drug Toxicity; Leukemia; Lymphoma; oral complications of cancer and cancer therapy; plasma cell neoplasm; radiation toxicity
  
• Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00077090 - Active, not recruiting
  Lymphedema; Radiation Fibrosis; perioperative/postoperative complications; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003576 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer
  
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00021450 - Recruiting
  stage II prostate cancer
  
• Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003893 - Active, not recruiting
  stage I breast cancer
  
• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00567580 - Not yet recruiting
  Prostate Cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002951 - Active, not recruiting
  Gastrointestinal Cancer; Neck Cancer; Oral Cancer; Throat Cancer
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Velafermin (CG53135-05) in Preventing Oral Mucositis in Patients Receiving Chemotherapy and/or Total-Body Irradiation Followed By An Autologous Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00124592 - Recruiting
  Cancer; Drug Toxicity; oral complications of cancer and cancer therapy; radiation toxicity
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00033696 - Active, not recruiting
  limited stage small cell lung cancer
  
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002490 - Active, not recruiting
  stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005957 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00041223 - Active, not recruiting
  Radiation Fibrosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00052910 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004859 - Active, not recruiting
  Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; ...
  
• Cisptain, CPT-11 and Celecoxib with Radiation Therapy and Surgery for Operable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00137852 - Active, not recruiting
  Resectable Esophageal Cancer
  
• Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00436267 - Recruiting
  Metastatic Cancer; Pancreatic Cancer
  
• Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00113386 - Active, not recruiting
  stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; ...
  
• Lymph Node Radiation Therapy in Patients with Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002851 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00028704 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
  
• Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00104741 - Recruiting
  stage II prostate cancer; stage III prostate cancer
  
• Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00046839 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00036712 - Recruiting
  Cancer; oral complications of cancer and cancer therapy; Pain
  
• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00377156 - Recruiting
  Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Lung Cancer; Prostate Cancer
  
• Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00077519 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00075868 - Active, not recruiting
  Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
  
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00047008 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00021320 - Active, not recruiting
  stage 0 esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; ...
  
• Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00084539 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; breast cancer in situ
  
• Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00450411 - Recruiting
  Prostate Cancer
  
• Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
  ClinicalTrials.gov Identifier: NCT00082927 - Recruiting
  Breast Cancer; Lung Cancer; metastatic cancer; Pain; Prostate Cancer
  
• Radiation Therapy and Cisplatin With or Without Amifostine in Treating Patients With Stage IIIB or Stage IVA Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00012012 - Active, not recruiting
  radiation toxicity; stage III cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ...
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00003799 - Active, not recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00068549 - Active, not recruiting
  Cervical Cancer
  
• Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00126555 - Recruiting
  squamous cell carcinoma of the skin; recurrent skin cancer
  
• Magnetic Resonance Imaging-Guided Internal Radiation Therapy Before and After External-Beam Radiation in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00045344 - Active, not recruiting
  Prostate Cancer
  
• Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00288080 - Recruiting
  Prostate Cancer
  
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003193 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00520702 - Recruiting
  Lung Cancer
  
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00057785 - Active, not recruiting
  oral complications of chemotherapy and head/neck radiation; radiation toxicity; stage I squamous cell carcinoma of the nasopharynx; ...
  
• Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
  ClinicalTrials.gov Identifier: NCT00077168 - Active, not recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Study of Peripheral Stem Cell Transplantation After Chemotherapy and Radiation Therapy in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005851 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003290 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy and Radiation Therapy in Treating Patients With Carcinoembryonic Antigen-Positive Solid Tumors That Have Metastasized to the Liver
  ClinicalTrials.gov Identifier: NCT00085241 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Metastatic Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00098995 - Active, not recruiting
  Cervical Cancer
  
• Amifostine in Protecting the Rectum in Patients Undergoing Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00045253 - Active, not recruiting
  Prostate Cancer; Radiation Toxicity
  
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00052559 - Recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00004125 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy in Treating Women With Resected Breast Cancer
  ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
  stage I breast cancer; stage II breast cancer